Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free NOEMW Stock Alerts

Noema Pharma (NOEMW) Competitors

Noema Pharma logo
$0.14 +0.00 (+2.94%)
As of 09/2/2026 12:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

NOEMW vs. AGD, AWP, THQ, ACP, and THW

Should you buy Noema Pharma stock or one of its competitors? Noema Pharma's main competitors and comparable companies include Abrdn Global Dynamic Dividend Fund (AGD), abrdn Global Premier Properties Fund (AWP), Abrdn Healthcare Opportunities Fund (THQ), Abrdn Income Credit Strategies Fund (ACP), and Abrdn World Healthcare Fund (THW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Noema Pharma compare to Abrdn Global Dynamic Dividend Fund?

Abrdn Global Dynamic Dividend Fund (NYSE:AGD) and Noema Pharma (NASDAQ:NOEMW) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

In the previous week, Abrdn Global Dynamic Dividend Fund had 1 more articles in the media than Noema Pharma. MarketBeat recorded 1 mentions for Abrdn Global Dynamic Dividend Fund and 0 mentions for Noema Pharma. Abrdn Global Dynamic Dividend Fund's average media sentiment score of 1.26 beat Noema Pharma's score of 0.00 indicating that Abrdn Global Dynamic Dividend Fund is being referred to more favorably in the media.

Company Overall Sentiment
Abrdn Global Dynamic Dividend Fund Positive
Noema Pharma Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abrdn Global Dynamic Dividend Fund$75.72MN/AN/AN/AN/A
Noema PharmaN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Abrdn Global Dynamic Dividend FundN/A N/A N/A
Noema Pharma N/A N/A N/A

Summary

Abrdn Global Dynamic Dividend Fund beats Noema Pharma on 3 of the 3 factors compared between the two stocks.

How does Noema Pharma compare to abrdn Global Premier Properties Fund?

abrdn Global Premier Properties Fund (NYSE:AWP) and Noema Pharma (NASDAQ:NOEMW) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Company Net Margins Return on Equity Return on Assets
abrdn Global Premier Properties FundN/A N/A N/A
Noema Pharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Global Premier Properties Fund$60.73MN/AN/AN/AN/A
Noema PharmaN/AN/AN/AN/AN/A

In the previous week, abrdn Global Premier Properties Fund's average media sentiment score of 0.00 equaled Noema Pharma'saverage media sentiment score.

Company Overall Sentiment
abrdn Global Premier Properties Fund Neutral
Noema Pharma Neutral

Summary

abrdn Global Premier Properties Fund beats Noema Pharma on 1 of the 1 factors compared between the two stocks.

How does Noema Pharma compare to Abrdn Healthcare Opportunities Fund?

Abrdn Healthcare Opportunities Fund (NYSE:THQ) and Noema Pharma (NASDAQ:NOEMW) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abrdn Healthcare Opportunities Fund-$28.02MN/AN/AN/AN/A
Noema PharmaN/AN/AN/AN/AN/A

In the previous week, Abrdn Healthcare Opportunities Fund had 1 more articles in the media than Noema Pharma. MarketBeat recorded 1 mentions for Abrdn Healthcare Opportunities Fund and 0 mentions for Noema Pharma. Abrdn Healthcare Opportunities Fund's average media sentiment score of 1.82 beat Noema Pharma's score of 0.00 indicating that Abrdn Healthcare Opportunities Fund is being referred to more favorably in the media.

Company Overall Sentiment
Abrdn Healthcare Opportunities Fund Very Positive
Noema Pharma Neutral

Company Net Margins Return on Equity Return on Assets
Abrdn Healthcare Opportunities FundN/A N/A N/A
Noema Pharma N/A N/A N/A

Summary

Abrdn Healthcare Opportunities Fund beats Noema Pharma on 2 of the 3 factors compared between the two stocks.

How does Noema Pharma compare to Abrdn Income Credit Strategies Fund?

Noema Pharma (NASDAQ:NOEMW) and Abrdn Income Credit Strategies Fund (NYSE:ACP) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership and earnings.

Company Net Margins Return on Equity Return on Assets
Noema PharmaN/A N/A N/A
Abrdn Income Credit Strategies Fund N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noema PharmaN/AN/AN/AN/AN/A
Abrdn Income Credit Strategies Fund$85.32MN/AN/AN/AN/A

In the previous week, Noema Pharma's average media sentiment score of 0.00 equaled Abrdn Income Credit Strategies Fund'saverage media sentiment score.

Company Overall Sentiment
Noema Pharma Neutral
Abrdn Income Credit Strategies Fund Neutral

Summary

Abrdn Income Credit Strategies Fund beats Noema Pharma on 1 of the 1 factors compared between the two stocks.

How does Noema Pharma compare to Abrdn World Healthcare Fund?

Abrdn World Healthcare Fund (NYSE:THW) and Noema Pharma (NASDAQ:NOEMW) are both finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Company Net Margins Return on Equity Return on Assets
Abrdn World Healthcare FundN/A N/A N/A
Noema Pharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abrdn World Healthcare Fund$86.53MN/AN/AN/AN/A
Noema PharmaN/AN/AN/AN/AN/A

In the previous week, Abrdn World Healthcare Fund's average media sentiment score of 0.00 equaled Noema Pharma'saverage media sentiment score.

Company Overall Sentiment
Abrdn World Healthcare Fund Neutral
Noema Pharma Neutral

Summary

Abrdn World Healthcare Fund beats Noema Pharma on 1 of the 1 factors compared between the two stocks.

Get Noema Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for NOEMW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NOEMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NOEMW vs. The Competition

Export
MetricNoema PharmaCapital Markets IndustryFinance SectorNASDAQ Exchange
Market CapN/A$5.58B$13.97B$12.67B
Dividend YieldN/A7.38%5.90%8.56%
P/E RatioN/A31.3825.9925.23
Price / SalesN/A1,267.00526.86104.30
Price / CashN/A48.0437.9552.08
Price / BookN/A1.952.116.10
Net IncomeN/A$418.14M$1.32B$348.86M
7 Day Performance-6.04%-0.89%-0.47%-1.90%
1 Month Performance-12.50%0.71%1.31%1.96%
1 Year PerformanceN/A7.20%11.72%15.30%

Noema Pharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOEMW
Noema Pharma
N/A$0.14
+2.9%		N/AN/A$0.00N/AN/AN/A
AGD
Abrdn Global Dynamic Dividend Fund
N/A$12.35
-0.1%		N/A+2.2%$0.00$75.72MN/AN/A
AWP
abrdn Global Premier Properties Fund
N/A$11.74
-0.5%		N/A-4.0%$0.00$60.73MN/AN/A
THQ
Abrdn Healthcare Opportunities Fund
N/A$19.78
-0.1%		N/A+16.5%$0.00-$28.02MN/A1,088
ACP
Abrdn Income Credit Strategies Fund
N/A$5.03
+0.1%		N/A-14.6%$0.00$85.32MN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:NOEMW) was last updated on 9/3/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel